KZR - Kezar Life Sciences, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
South San Francisco,
United States
Type: Equity
KZR price evolution
KZR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $28.28 | $33.03 | $35.49 | |
| Short term investments | $135.91 | $146.77 | $165.88 | |
| Net receivables | $1.09 | $1.69 | $3.06 | $2.29 |
| Inventory | ||||
| Total current assets | $156.38 | $167.62 | $185.61 | $206.95 |
| Long term investments | ||||
| Property, plant & equipment | $5.29 | $5.78 | $8.02 | $8.69 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $12.3 | $13.52 | $14.29 | |
| Total investments | $135.91 | $146.77 | $165.88 | |
| Total assets | $164.09 | $179.92 | $199.13 | $221.24 |
| Current liabilities | ||||
| Accounts payable | $3.46 | $2.26 | $5.06 | $8.25 |
| Deferred revenue | ||||
| Short long term debt | $5.87 | $4.44 | $3.01 | |
| Total current liabilities | $20.43 | $17.5 | $16.16 | $17.74 |
| Long term debt | $6.35 | $11.74 | $13.85 | $15.92 |
| Total noncurrent liabilities | $11.74 | $13.85 | $15.92 | |
| Total debt | $17.61 | $18.29 | $18.93 | |
| Total liabilities | $30.04 | $29.24 | $30.01 | $33.66 |
| Shareholders' equity | ||||
| Retained earnings | -$414.28 | -$393.97 | -$372.42 | -$350.76 |
| Other shareholder equity | $0.11 | -$0.39 | -$0.35 | -$0.13 |
| Total shareholder equity | $150.69 | $169.12 | $187.57 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $35.49 | $40.46 | $62.88 | $21.23 |
| Short term investments | $165.88 | $236.1 | $145.47 | $119.22 |
| Net receivables | $2.29 | $0.07 | $0.8 | |
| Inventory | ||||
| Total current assets | $206.95 | $285.72 | $211.65 | $144.81 |
| Long term investments | ||||
| Property, plant & equipment | $8.69 | $13.17 | $6 | $6.75 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $14.29 | $13.85 | $6.28 | $7.03 |
| Total investments | $165.88 | $236.1 | $145.47 | $119.22 |
| Total assets | $221.24 | $299.57 | $217.93 | $151.84 |
| Current liabilities | ||||
| Accounts payable | $8.25 | $2.48 | $2.03 | $2.36 |
| Deferred revenue | ||||
| Short long term debt | $3.01 | $2.56 | $1.2 | $1.04 |
| Total current liabilities | $17.74 | $11 | $8.21 | $6.44 |
| Long term debt | $15.92 | $9.83 | $12.85 | $4.42 |
| Total noncurrent liabilities | $15.92 | $18.7 | $12.85 | $4.42 |
| Total debt | $18.93 | $21.26 | $14.04 | $5.46 |
| Total liabilities | $33.66 | $29.7 | $21.06 | $10.86 |
| Shareholders' equity | ||||
| Retained earnings | -$350.76 | -$248.89 | -$180.65 | -$126.02 |
| Other shareholder equity | -$0.13 | -$0.92 | -$0.29 | -$0.14 |
| Total shareholder equity | $187.57 | $269.87 | $196.88 | $140.98 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $16.3 | $17.17 | $22.64 | |
| Selling, general & administrative | $5.6 | $6.54 | $5.76 | |
| Total operating expenses | $21.95 | $23.38 | $23.71 | $34.59 |
| Operating income | -$23.38 | -$23.71 | -$34.59 | |
| Income from continuing operations | ||||
| EBIT | -$21.15 | -$21.26 | -$31.86 | |
| Income tax expense | ||||
| Interest expense | $1.64 | $0.4 | $0.4 | $0.4 |
| Net income | ||||
| Net income | -$20.31 | -$21.55 | -$21.66 | -$32.26 |
| Income (for common shares) | -$21.55 | -$21.66 | -$32.26 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7 | |||
| Cost of revenue | ||||
| Gross Profit | $7 | |||
| Operating activities | ||||
| Research & development | $85.7 | $51.01 | $38.94 | $30.98 |
| Selling, general & administrative | $26.54 | $20.15 | $15.72 | $11.97 |
| Total operating expenses | $118.42 | $71.16 | $54.66 | $42.95 |
| Operating income | -$111.42 | -$71.16 | -$54.66 | -$42.95 |
| Income from continuing operations | ||||
| EBIT | -$100.32 | -$67.05 | -$54.47 | -$41.74 |
| Income tax expense | ||||
| Interest expense | $1.55 | $1.19 | $0.16 | |
| Net income | ||||
| Net income | -$101.87 | -$68.24 | -$54.63 | -$41.74 |
| Income (for common shares) | -$101.87 | -$68.24 | -$54.63 | -$41.74 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$21.55 | -$21.66 | -$32.26 | |
| Operating activities | ||||
| Depreciation | $0.26 | $0.26 | $0.28 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.08 | $3.43 | $3.22 | |
| Total cash flows from operations | -$17.03 | -$22.86 | -$18.98 | |
| Investing activities | ||||
| Capital expenditures | -$0 | |||
| Investments | $12.22 | $20.41 | $27.88 | |
| Total cash flows from investing | $56.68 | $12.22 | $20.41 | $27.88 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.06 | $0.06 | ||
| Net borrowings | ||||
| Total cash flows from financing | $0.06 | $0.06 | $0.06 | |
| Effect of exchange rate | $0.01 | $0 | -$0.01 | $0.04 |
| Change in cash and equivalents | -$0.64 | -$4.76 | -$2.46 | $8.99 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$101.87 | -$68.24 | -$54.63 | -$41.74 |
| Operating activities | ||||
| Depreciation | $1.07 | $1.02 | $1.51 | $1.54 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $18.14 | $14.01 | $7.6 | $4.94 |
| Total cash flows from operations | -$81.64 | -$58.85 | -$42.44 | -$36.95 |
| Investing activities | ||||
| Capital expenditures | -$1.8 | -$1.58 | -$0.32 | -$0.19 |
| Investments | $77.85 | -$89.81 | -$28.13 | -$56.3 |
| Total cash flows from investing | $76.05 | -$91.39 | -$28.44 | -$56.5 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.64 | $127.86 | $103.05 | $99.64 |
| Net borrowings | $9.53 | |||
| Total cash flows from financing | $0.64 | $127.86 | $112.58 | $99.64 |
| Effect of exchange rate | -$0 | -$0.05 | -$0.05 | $0.08 |
| Change in cash and equivalents | -$4.96 | -$22.43 | $41.65 | $6.28 |
News
Fundamentals
| Market cap | $28.82M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 7.30M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$95.78M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -0.30 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$13.13 |
|---|---|
| ROA | -50.12% |
| ROE | N/A |
| Debt/Equity | 0.18 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 7.65 |
| Quick ratio | N/A |